2011
DOI: 10.1182/blood.v118.21.4765.4765
|View full text |Cite
|
Sign up to set email alerts
|

Burden of Illness of FLT-3 Mutated Acute Myeloid Leukemia (AML)

Abstract: 4765 Introduction: Patients with FLT3-mutated AML have poor prognoses due to shorter survival, a high incidence of relapse, and a lack of effective treatment options. Limited information is published on the burden of illness (BOI) of AML, especially for patients with FLT3-mutated disease. This study reviewed the epidemiologic, clinical, humanistic, and economic literature and estimated the burden of FLT3-mutated AML in the US. … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles